Arbutus Biopharma
ABUS
#7051
Rank
HK$4.83 B
Marketcap
HK$31.51
Share price
-1.23%
Change (1 day)
-6.05%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): HK$1.20 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are HK$0.18 Billion. In 2025 the company made an earning of -HK$0.27 Billion, an increase over its 2024 earnings that were of -HK$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.20 B-557.09%
2025 -HK$0.27 Billion-52.09%
2024 -HK$0.55 Billion-4.02%
2023 -HK$0.58 Billion12.05%
2022 -HK$0.51 Billion-14.74%
2021 -HK$0.6 Billion19.61%
2020 -HK$0.5 Billion-61.69%
2019 -HK$1.31 Billion171.23%
2018 -HK$0.49 Billion-43.58%
2017 -HK$0.86 Billion-77.77%
2016 -HK$3.84 Billion532.77%
2015 -HK$0.61 Billion99.05%
2014 -HK$0.31 Billion175.82%
2013 -HK$0.12 Billion-143.7%
2012 HK$0.25 B-399.11%
2011 -HK$84.45 Million-39.03%
2010 -HK$0.14 Billion100.55%
2009 -HK$69.07 Million-28.56%
2008 -HK$96.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$16.94 Million-101.41% Bahamas
NRC Health
NRC
HK$0.11 B-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA